
Alana Harris Dent
Examiner (ID: 7014)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 1512 |
| Issued Applications | 526 |
| Pending Applications | 351 |
| Abandoned Applications | 660 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13901821
[patent_doc_number] => 20190040115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Immunotherapy against melanoma and other cancers
[patent_app_type] => utility
[patent_app_number] => 16/167656
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16167656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/167656 | Immunotherapy against melanoma and other cancers | Oct 22, 2018 | Issued |
Array
(
[id] => 14948391
[patent_doc_number] => 10435454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-08
[patent_title] => Immunotherapy against melanoma and other cancers
[patent_app_type] => utility
[patent_app_number] => 16/165121
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 47989
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165121 | Immunotherapy against melanoma and other cancers | Oct 18, 2018 | Issued |
Array
(
[id] => 14731443
[patent_doc_number] => 10385111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Immunotherapy against melanoma and other cancers
[patent_app_type] => utility
[patent_app_number] => 16/165275
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 47918
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165275 | Immunotherapy against melanoma and other cancers | Oct 18, 2018 | Issued |
Array
(
[id] => 14731441
[patent_doc_number] => 10385110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Immunotherapy against melanoma and other cancers
[patent_app_type] => utility
[patent_app_number] => 16/165116
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 48051
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165116 | Immunotherapy against melanoma and other cancers | Oct 18, 2018 | Issued |
Array
(
[id] => 16628763
[patent_doc_number] => 20210047416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1
[patent_app_type] => utility
[patent_app_number] => 16/756790
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756790
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756790 | TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1 | Oct 17, 2018 | Pending |
Array
(
[id] => 13901815
[patent_doc_number] => 20190040112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/162333
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48065
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16162333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/162333 | Immunotherapy against melanoma and other cancers | Oct 15, 2018 | Issued |
Array
(
[id] => 13955653
[patent_doc_number] => 20190054170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT
[patent_app_type] => utility
[patent_app_number] => 16/143889
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143889 | MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT | Sep 26, 2018 | Pending |
Array
(
[id] => 13955653
[patent_doc_number] => 20190054170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT
[patent_app_type] => utility
[patent_app_number] => 16/143889
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26839
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16143889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/143889 | MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT | Sep 26, 2018 | Pending |
Array
(
[id] => 13793365
[patent_doc_number] => 20190010221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => ANTI-BAG3 ANTIBODIES FOR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/141911
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141911 | Anti-BAG3 antibodies for therapeutic use | Sep 24, 2018 | Issued |
Array
(
[id] => 14454239
[patent_doc_number] => 10323071
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-18
[patent_title] => Recombinant polypeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/138204
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 23108
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138204
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138204 | Recombinant polypeptides and methods of use thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 14360153
[patent_doc_number] => 10301364
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-05-28
[patent_title] => Recombinant polypeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/138219
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 23124
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138219 | Recombinant polypeptides and methods of use thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 14596849
[patent_doc_number] => 10351607
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-07-16
[patent_title] => Recombinant polypeptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/138212
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 23090
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138212 | Recombinant polypeptides and methods of use thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 14501239
[patent_doc_number] => 20190194274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => RECOMBINANT POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/138224
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138224 | Recombinant polypeptides and methods of use thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 16114449
[patent_doc_number] => 20200209247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS FOR IDENTIFYING MYELOMA TUMOR-INITIATING CELLS AND TARGETED THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/644106
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644106
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644106 | METHODS FOR IDENTIFYING MYELOMA TUMOR-INITIATING CELLS AND TARGETED THERAPY | Sep 16, 2018 | Abandoned |
Array
(
[id] => 14652791
[patent_doc_number] => 20190233524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/132339
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16132339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/132339 | THERAPEUTIC COMBINATION AND METHOD FOR TREATING CANCER | Sep 13, 2018 | Abandoned |
Array
(
[id] => 14102997
[patent_doc_number] => 20190093174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL CANCERS TARGETING THE SIRPALPHA CD47 INTERACTION
[patent_app_type] => utility
[patent_app_number] => 16/118038
[patent_app_country] => US
[patent_app_date] => 2018-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/118038 | COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL CANCERS TARGETING THE SIRPALPHA CD47 INTERACTION | Aug 29, 2018 | Abandoned |
Array
(
[id] => 13870875
[patent_doc_number] => 20190031778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => ANTI-NME ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 16/111862
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16111862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/111862 | ANTI-NME ANTIBODY | Aug 23, 2018 | Abandoned |
Array
(
[id] => 13870877
[patent_doc_number] => 20190031779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => ANTI-CANCER PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/111894
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30486
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16111894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/111894 | Method of treating an NME7 expressing cancer with a peptide | Aug 23, 2018 | Issued |
Array
(
[id] => 16108643
[patent_doc_number] => 20200206344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/640942
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64262
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -83
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16640942
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/640942 | METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES | Aug 19, 2018 | Pending |
Array
(
[id] => 14069517
[patent_doc_number] => 20190083646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => MUTANT SMOOTHENED AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/054112
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054112 | MUTANT SMOOTHENED AND METHODS OF USING THE SAME | Aug 2, 2018 | Abandoned |